Академический Документы
Профессиональный Документы
Культура Документы
Introduction - CNS
Brain + Spinal Chord Parallels Autonomic Nervous System Not just Norepinephrine & Acetylcholine
Manipulating a diseased pathway also affects healthy pathways CNS drugs NOTORIOUS for causing side effects!
Introduction - CNS
PNS
involuntary
Somatic
voluntary
Introduction - CNS
SYMPATHETIC
PARASYMPATHETIC
From: Clinical Pharmacology Made Ridiculously Simple, 2nd Ed., James Olson, MD, PhD.
Neurotransmitters - Brain
Monoamines (Catecholamines)
Norepinephrine sympathetic transmitter Dopamine 5-hydroxytryptamine (5-HT or Serotonin) Adrenergic: Refers to neurons that use catecholamines as neurotransmitters at a synapse when a nerve impulse passes i.e. sympathetic fibers.
Acetylcholine parasympathetic transmitter Gamma-amino butyric acid (GABA) - inhibitory Excitatory amino acids (EAA) - glutamate Opioids Other talk about as they come up.
OH HO NH2
Norepinephrine
1. a.a. tyrosine is converted to L-dopa which is then hydroxylated to Dopamine &-hydroxylase converts dopamine to norepi Norepi release Ca2+ Receptor binding (Also see #5 #7)
amine
HO
Catechol
3. 4.
8.
Catechol O-methyl transferase degrades catecholamines 9. Reuptake into presynaptic neuron 10. Repackaging 11. Degraded by mitochondrial MAO 12. Path for indirect sympathomimetics
Dopaminergic Receptors
HO
Storage vesicles
HO
NH2
dopamine
Dopamine Reuptake
Postsynaptic Receptors
HO
Serotonin
5-HT
NH2
Tryptophan is hydroxylated and N H decarboxylated to form 5-HT 5-hydroxytryptamine In Neurons 5-HT is:
5-HT released by inhibitory neurons Stimulates 5-HT1, 5-HT2, or 5-HT3 receptors Antagonists: Depression, Attention Deficit Disorder (ADD), headaches, and nausea
Acetylcholine
O
N+
acetylcholine
1.
Choline acetyltransferase catalyzes formation of acetylcholine from choline and acetyl CoA 2. Storage in vesicles 3. Ca2+ stimulated release 4. Receptor binding Nicotinic Muscarinic - CNS 9. Reuptake and hydrolysis by acetylcholine esterase 10. Breakdown products recycled
Acetylcholine
Correct imbalance of acetylcholine and dopamine neurotransmission Imbalance produced by degredation of dopaminergic nerves No other major uses!
GABA
H2N OH
gamma aminobutyric acid Inhibitory amino acid Synthesized from glutamate Stored in presynaptic vesicles for release Binds to GABA-A or GABA-B receptors
Receptors reside on two subunits of a four subunit complex This regulates a chloride ion channel Hyperpolarizes the neuron Makes it more difficult to stimulate the neuron with excitatory neurotransmitters
Benzodiazepines enhance GABA-A receptors ONLY! GABA enhancers (benzodiazepines, barbiturates) used:
Glutamate and others Stimulation of EAA receptors increases cation conductance Important in learning, memory, etc. Glutamate-induced toxicity implicated in
Alzheimer s Huntington s Stroke Epilepsy Amyotrophic Lateral Schlerosis (ALS) Riluzole - Rilutek
Opiate receptors located along the periaquiductal gray matter Opiate Receptor Agonists:
Morphine and related compounds act on opiate receptors to relieve pain In times of stress & pain, endogenous peptides act on opiate receptors
Sympathomimetic Actions
Direct
Indirect
Mixed
Scheduled Drugs
Schedule I
Drugs with a high abuse risk. These drugs have NO safe, accepted medical use in the United States. Ex. heroin, marijuana, LSD, PCP, and crack cocaine Drugs with a high abuse risk, but also have safe and accepted medical uses in the United States. These drugs can cause severe psychological or physical dependence. Ex. morphine, cocaine, oxycodone (Percodan), methylphenidate (Ritalin), and dextroamphetamine (Dexedrine) Drugs categorized as "prescription drugs . Schedule III drugs have some potential for abuse, but less than I and II. The potential for abuse of Schedule IV drugs is less than Schedule III, and Schedule V is less than IV. Ex. acetaminophen with codeine (Tylenol No.3), paregoric, hydrocodone with acetaminophen (Vicodin), diazepam (Valium), alprazolam (Xanax), propoxyphene (Darvon), and pentazocine (Talwin).
Schedule II
Schedule III - V
Analeptics
O H3 C O N
PNS stimulant
N N CH3 Caffeine
Indications: fatigue, drowsiness, adjunctive in analgesic preparations, respiratory depression (injection), actopic dermatitis, obesity in combo with ephedrine, headache, treatment of excited or comatose alcoholic patients, postprandial hypotension MOA: non-selective antagonist of adenosine receptors, increased cAMP via phosphodiesterase inhibition
Analeptics
O N
O
PNS stimulant
HCl
N CH3
Indications: postanesthesia drug induced respiratory depression or apnea due to drugs other than muscle relaxants, stimulation of drug induced CNS depression, COPD associated with acute hypercapnia (CO2) , apnea of prematurity MOA: stimulates peripheral carotid chemoreceptors increases tidal volume and respiration rate, as dose is increased medullary respiratory centers are stimulated Indications: Narcolepsy (p. 240 G&G)
S O
NH2 O
MOA: Unknown, similar to sympathomimetic agents Racemic drug with differing half lives - one enantiomer has 3X lifetime of others
Modafinil - Provigil
CNS Stimulants:Amphetamines
CH3 NH3+HSO4-
Simplest is 1-phenyl-2-aminopropane CNS stimulant, anorectic, sympathomimetic actions Indications: ADHD (attention deficit hyperactivity disorder, narcolepsy) MOA: indirect-acting dopaminergic & noradrenergic agonist
Enhances release and prevents re-uptake of dopamine Can be attenuated by dopamine antagonists (chlorpromazine, haloperidol)
CNS effects: increased arousal and wakefulness mood alterationincreased confidence, ability to concentrate, exhilaration, euphoria; increased motor activity, anorexia, insomnia Prolonged exposure can cause amphetamine psychosis
Dopaminergic Receptors
Storage vesicles
Postsynaptic Receptors
Amphetamines
K-carbon R
CH3
NH2
Structure-Activity relationships Few derivatives retain pharmacologic activity. Fewer retain potency! Classes:
Aryl substitution
Amine substitution
MOST AGENTS!
decrease in activity
Amphetamines
CH3 NH2+HClCH3
CNS effects: increased arousal and wakefulness mood alteration-increased confidence, ability to concentrate, exhilaration, euphoria; increased motor activity, anorexia, insomnia CV effects - similar to sympathomimetic amines NO LONGER indicated for obesity and as an antidepressant due to high addiction potential and CV side effects Problems: addiction and tolerance, toxic psychosis Underlying psychosis, hypertension, angina, hyperthyroidism can be aggravated
Amine substitution
Amphetamines
CH3 NHCH3 OH HO CH3 NHCH3
CNS effects: increased arousal and wakefulness mood alteration-increased confidence, ability to concentrate, exhilaration, euphoria; increased motor activity, anorexia, insomnia CV effects - similar to sympathomimetic amines: E-adrenergic effects Indications: Decongestant Ephidrine MORE effective than pseudoephidrine. Pseudoephidrine given to reduce side-effects CAUTION: Use carefully with patients with enlarged prostate, hypertension, or on MAO inhibitors
Ephidrine
Pseudoephidrine
Amphetamine-like Drugs
HN CH3O OH Methylphenidate - Ritalin
Indications: ADHD, narcolepsy; unlabeled uses treatment of depression in elderly, cancer and post-stroke patients, postanesthesia related hiccups MOA: mild CNS stimulant similar to amphetamines but with an unknown mechanism Patient info: Take last dose prior to 6 pm to avoid insomnia, do not crush or chew SR products NEW for 2002: Focalin dexmethylphenidate the (R,R)(+) diastereomer that is more pharmacologically active
O N O NH2 Cylert
Indications: ADHD, narcolepsy 2nd line agent MOA: mild CNS stimulant similar to amphetamines but minimal sympathomimetic effects - may potentiate dopaminergic mechanisms Patient info: Take single daily dose in the morning (insomnia) Long-term effects of these drugs on children CNS development UNKNOWN! Life threatening hepatic failure!
Pemoline -
Amphetamine-like Drugs
O -Cl+H2N
Indications: ADHD MOA: Still under investigation. Thought to be a norepinephrine reuptake inhibitor. Increases the available stores of norepinephrine believed necessary for regulation of impulse control. NEW for 2003 - First demonstrated effective in both adults and children Metabolized extensively by CYP2D6 (7% caucasion, 2% AA slow met.) Side effects: Dry mouth (21%), insomnia (16%), nausea (12%), dizziness (6%) + others.
Anorexiants
Indications: short-term adjunct used in conjunction with caloric restriction for exogenous obesity (< 8-12 weeks recommended) MOA: Stimulate the satiety center in the hypothalamic and limbic regions of the brain producing a loss of appetite Two classes: 1. 2. Amphetamine like analogs phenethylamines Non-phenethylamines
Patient information: Best if taken on an empty stomach (except mazindol which can be taken with food to prevent GI upset), avoid taking medication late in the day to avoid insomnia, do not crush or chew. NOTE: tolerance will occur if taken too frequently Can produce psychological disturbances due to caloric restrictions: can lead to psychosis indistinguishable from schizophrenia, can lower seizure thresholds, NOT recommended if CV disease present - monitor BP in hypertensive patients continually
Anorexiants
CH3 N CH3
Amphetamine-like
25 and 50 mg tablets 1-3 times daily depending on response Short-term weight loss
HCl
Amine substitution
O
CH3 N
HCl
CH3
25 mg tablet tid one hour before meals and midevening to overcome night hunger if necessary 75 mg SR tablet once daily in midmorning Short-term weight loss
Anorexiants
Substitution at the E-carbon
NH3+ClH3C CH3
Amphetamine-like
Dosing 8 mg tid 30 minutes prior to meals or 15 to 37.5 mg as a single dose before breakfast or 10-14 hours before sleeping
Recommended for obese patients based on body mass index (BMI = Weight (kg)/Height (# meters squared)): >30 kg/meter sq or >27 kg/meter square in the presence of other risk factors such as hypertension, diabetes, dyslipidemias
Cl
MOA: reuptake inhibition of norepinephrine, serotonin, dopamine via metabolites of this drug Monitor BP in hypertensive patients, dependence possible, MD must be informed of any OTCs
Anorexiants: Non-phenylethylamines
Cl OH N N Mazindol - Mazanor, Sanorex Cl
35 mg tablet or capsule bid or tid one hour before meals 105 mg SR capsule in the morning before breakfast